Cryptocurrency & Digital Assets

A new multi-year deal for advanced battery materials highlights Volkswagen's push for supply chain control and Cabot's strategic green energy pivot.

The 2026 auto show reveals a market in flux. Hybrids are back, EVs adapt post-rebate, and the hunt for affordable cars intensifies. What's next?

A $7M auction saw a Purdey gun fetch $209K, revealing a red-hot market where history, craftsmanship, and investment potential drive record prices.

Wearable Devices and Rokid partner to bring touchless gesture control to smart glasses, promising a future where a flick of a finger runs your world.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

New system from Montrose tackles a major methane source, promising greater accuracy, technician safety, and faster action on climate goals.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

A new partnership brings a complex wealth-building insurance product to the digital age, offering instant decisions and no medical exams. Is this the future?

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

A new joint venture provides crucial short-term loans, aiming to unlock permanent financing for affordable housing projects facing a critical funding gap.

With its revolutionary Prime Editing tech showing promise, Prime Medicine faces a pivotal moment at the J.P. Morgan conference. Can it justify its new strategy?

A Tennessee company's patented 1-to-1 CBD and CBDA formula shows promise in fighting inflammation, setting the stage for a new class of FDA-regulated drugs.

A new blood test in Western Canada promises to detect 59 cancers early. But with a high price tag and pending approval, it raises critical questions.

Evergy is repurchasing $244M of its convertible notes, a strategic play to reduce future stock dilution and manage complex arbitrage market ripples.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

Digital banking leader Finshape appoints Neil Budd as CEO, signaling an aggressive global expansion fueled by strategic acquisitions and a focus on AI.

The banking giant's investment in clearinghouse Ubyx signals a major shift towards mainstream adoption of tokenized deposits and stablecoins.

The healthcare virtual assistant market is set to explode, promising radical efficiency but raising critical questions about privacy, bias, and patient trust.

A new multi-target deal combines cutting-edge platforms to create next-gen cancer drugs, aiming to improve precision and patient outcomes.

The Japanese government's 'SUI COLLECTION' is showcasing hidden artisanal treasures to the world, blending tradition with modern luxury in a bold cultural push.